Life Sciences & Biopharma

Life Science and Biopharma vertical focusses on disruptive innovations in the field such as precision medicine, genomics, next-generation sequencing, molecular biology, and in-vitro diagnostics among other new-age treatment therapies. This vertical keeps track of rapid growth of gene therapy, cell therapy, biologics, and next-generation vaccines that are driving the market, as well as on improves visibility on emerging trends, regulations, and competitor landscape that promises to address key challenges in the healthcare industry.

To Know more about Life Sciences & Biopharma Practice Contact Us Or email us [email protected]

Global Next-Generation Biomanufacturing Market: Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.

Request Sample

Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

The recombinant cell culture supplements market analysis by BIS Research projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million revenue in 2018, in terms of value.

Request Sample

Global Stem Cell Therapy Market: Focus on Treatment Type, Cell Source, Indication,11 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

The Global Stem Cell Therapy Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.

Request Sample

Global Carrier Screening Market: Focus on Product Type, Technology Type, 18 Countries Data, Disease Type, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2029

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.

Request Sample

North America Cannabis Market: Focus on Product Type, Medical Application, Distribution Channel, Countries Data (U.S. and Canada) and Competitive Landscape – Analysis and Forecast, 2019-2025

The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.

Request Sample

Asia-Pacific In-Vitro Fertilization Market: Focus on Device Type, Reagent Type, Services, Procedure Type, End Users, Six Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.

Request Sample

Global Sports Medicine Market: Focus on Products, Applications and 24 Countries Data Analysis and Forecast, 2019-2026

The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.

Request Sample

Global Anti-Aging Devices Market: Focus on Product Type, Device Type, Target Area, Consumer Analysis, 28 Countries Data, and Competitive Landscape, Analysis and Forecast 2018 - 2028

The global anti-aging devices market was estimated at $6.37 billion in 2017 and is anticipated to reach $15.77 billion by 2028.

Request Sample

Global Industrial Microbiological QC Market: Focus on Technology Trends, Application, Regulatory Framework, and Competitive Mapping Analysis and Forecast, 2019-2028

The global industrial microbiological QC market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.

Request Sample

Latin America Cell Analysis Market: Focus on Products Type, End Users, 5 Countries Data, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2025

The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.

Request Sample

Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region – Analysis and Forecast, 2018 to 2028

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.

Request Sample

Global Human Microbiome Modulators Market: Focus on Non-Dairy Supplements, Drugs, Applications, 15 Countries Data, Pipeline Product Mapping, and Competitive Landscape – Analysis and Forecast, 2018-2023

The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.

Request Sample

Global Vaccine Market: Focus on Product Type (Next-Generation Vaccine), Route of Administration, Disease Type, 18 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.

Request Sample

Global Nanopharmaceutical Drugs Market: Focus on Nanodrugs and its Application in Therapeutics, Competitive Landscape, and Country - Analysis and Forecast (2018-2026)

The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.

Request Sample

Global Rare Disease Diagnostics Market: Focus on Genetic Diseases, Service Providers, Competitive Landscape, and Country - Analysis and Forecast, 2018-2025

The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.

Request Sample

Global Enzymes Market: Focus on Genetic Engineering Enzymes, Products, Applications, and Regional Analysis (15 Countries) - Analysis and Forecast, 2018-2025

The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025. The growing demand for enzymes in various industries is the major reason for the growth of this market.

Request Sample

Global Biosensors Market - Analysis and Forecast (2018 -2027) (Focus on Product, Application, 19 Countries Analysis, and Competitive Landscape)

The global biosensors market was valued $1.46 billion in 2017. With the growing prominence of point of care testing services, aided by rising geriatric population and rapid incorporation of biosensing technologies in non-medical applications, the global biosensors market is anticipated to witness an impressive double-digit growth rate.

Request Sample

Global Point of Care Testing Market : Focus on Application, Market Share, Product Mapping and Country - Analysis and Forecast (2017-2026)

The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.

Request Sample

Global Regenerative Medicines Market : Analysis and Forecast (2017-2025) (Focus on Therapy, Applications, Market Share Analysis, 22 Country Analysis, and Competitive Landscape)

The regenerative medicines market generated $17.03 billion revenue in 2016. The North America regenerative medicines market currently holds 39% percent of the global regenerative medicines market. Technological innovations across the various segments of the regenerative medicine have propelled growth in the recent past in the region.

Request Sample

Global Women's Health Product (Drugs & Devices) Market, Analysis and Forecast (2017-2023) (Focus on Contraceptives, Menopausal Hot Flash Drug Market, Country Analysis, and Competitive Landscape)

The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.

Request Sample

Global Industrial Microbiology Market - Analysis and Forecast (2017-2025) (Focus on Competitive Landscape, Market Dynamics, Country Analysis, End Users, Application, and Patent Landscape)

The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.

Request Sample

Global Biologics Drug Discovery Market Analysis and Forecast, (2017-2025) (Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape)

The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is estimated to grow over $22.7 billion by 2025. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.

Request Sample

Global Biologics Market -Analysis and Forecast (2017-2025) (Focus on Pipeline Analysis, Product Type, Therapeutic Application, Country Analysis, and Market Dynamics)

The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.

Request Sample

Global Gastro Esophageal Reflux Disease (GERD) Drug and Devices Market - Analysis and Forecast (2017-2023)

The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.

Request Sample

Global IVD(In-Vitro Diagnostics) Market: Analysis and Forecast 2017-2023 (Focus on Product Type, Test Type, Application, and Competitive Landscape)

IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare spending globally. The category’s rate of growth is accelerating due to a number of key macro forces, such as demand from emerging economies, aging population, evolving clinician attitudes, and a much needed push towards theranostics and personalized medicine.

Request Sample

Product is added to your Wishlist

NEWSLETTER SIGNUP

Upcoming Events

Webinar: Ventilators for COVID-19: How Companies are Breaking the Entry Barriers

https://zoom.us/webinar/register/971585895522 When: 09 Apr - 09 Apr, 2020
Where: Free webinar at https://zoom.us/webinar/regis
Representative- BIS Research Analysts
Type of Engagement- Speaker

Spar 3D Expo and Conference

https://www.spar3d.com/event/ When: 03 Jun - 05 Jun, 2020
Where: Mccormick Place, Chicago, IL
Representative- Mr. Rahul Papney (Principal Consultant, Team
Type of Engagement- Research Partner

Commercial UAV Expo Americas

https://www.expouav.com/ When: 15 Sep - 17 Sep, 2020
Where: Paris Las Vegas, Las Vegas, USA
Representative- Mr. Rahul Papney (Principal Consultant, Team
Type of Engagement- Research Partner

Commercial UAV Expo Europe

https://www.expouav.com/europe/ When: 01 Dec - 03 Dec, 2020
Where: RAI Amsterdam, Amsterdam, Netherlands
Representative- Mr. Rahul Papney (Principal Consultant, Team
Type of Engagement- Research Partner

Amsterdam Drone Week

https://www.amsterdamdroneweek.com/ When: 01 Dec - 03 Dec, 2020
Where: RAI Amsterdam, Amsterdam, Netherlands
Representative- Mr. Rahul Papney (Principal Consultant, Team
Type of Engagement- Research Partner

Life Sciences & Biopharma

Top Market Research Reports:

The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.

The recombinant cell culture supplements market analysis by BIS Research projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million revenue in 2018, in terms of value.

The Global Stem Cell Therapy Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.

The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.

The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.

The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.

The global anti-aging devices market was estimated at $6.37 billion in 2017 and is anticipated to reach $15.77 billion by 2028.

The global industrial microbiological QC market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.

The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.

The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.

The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.

The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.

The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.

The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025. The growing demand for enzymes in various industries is the major reason for the growth of this market.

The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.

The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.

The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.

The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.

The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.

NEWSLETTER SIGNUP

Categories

Upcoming Events

Webinar: Ventilators for COVID-19: How Companies are Breaking the Entry Barriers

Spar 3D Expo and Conference

Commercial UAV Expo Americas

Commercial UAV Expo Europe

Amsterdam Drone Week

Twitter Feeds

Get yourself updated on key emerging technology markets